Hangzhou Aichek Medical Technology Co.,Ltd

Hangzhou Aichek Medical Technology Co.,Ltd

Manufacturer from China
Active Member
4 Years
Home / Products / LFT Lateral Flow Test /

98% Myoglobin Cardiac Marker LFT Lateral Flow Test Self Test Kit RTK

Contact Now
Hangzhou Aichek Medical Technology Co.,Ltd
City:hangzhou
Province/State:zhejiang
Country/Region:china
Contact Person:MrEdward YU
Contact Now

98% Myoglobin Cardiac Marker LFT Lateral Flow Test Self Test Kit RTK

Ask Latest Price
Video Channel
Brand Name :Aichek
Model Number :MYO-A01
Certification :CE
Place of Origin :China
MOQ :5000 Test
Price :negotiable
Payment Terms :T/T
Supply Ability :negotiable
Packaging Details :40box/carton
Storage :2℃-30℃
Sample Type :Blood
User :Professional
Accuracy :98.1% (96.3%-99.2%)
Certificate :CE ISO 13485
OEM :OEM customized packing avaliable
Formats :25T/box 1T/box
After-sales Service :Available
Key words :Cardiac Myoglobin Rapid One Step Test with CE certificate Test Device
Combo Device :Any 2 To 12 Of The Products Can Be Integrated Into A Combo Cassette
more
Contact Now

Add to Cart

Find Similar Videos
View Product Description

Cardiac Myoglobin Rapid One Step Test with CE certificate Test Device

Product Name

Cardiac Myoglobin One Step Test

Formats Strip(3mm)Device(4mm)
Place of Origen China
Specimen Blood
Read Time 15 minutes
Shelf life 2 years
Package 25 device/box or 50 strip/Box
Storage 2℃-30℃

For professional in vitro diagnostic use only.

INTENDED USE

The Myoglobin Rapid Test Device (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of human Myoglobin in whole blood, serum or plasma as an aid in the diagnosis of myocardial infarction (MI).

Sensitivity and Specificity

The Myoglobin Rapid Test Device (Whole Blood/Serum/Plasma) has been evaluated with a leading commercial Myoglobin EIA test using clinical specimens. The results show that the sensitivity of the MYO Myoglobin Rapid Test Device (Whole Blood/Serum/Plasma) is 100% and the specificity is 97.8% relative to the leading EIA test.

Myoglobin Rapid Test vs. EIA

Method EIA

Total

Results

Myoglobin Rapid Test Results Positive Negative
Positive 59 8 67
Negative 0 356 356
Total Results 59 364 423

Relative Sensitivity: 100% (94.0%-100%)*

Relative Specificity: 97.8% (95.7%-99.0%)*

Accuracy: 98.1% (96.3%-99.2%)* 95% Confidence Interval

SUMMARY

Myoglobin (MYO) is a heme-protein normally found in skeletal and cardiac muscle with a molecular weight of 17.8 kDa. It constitutes about 2 percent of total muscle protein and is responsible with transporting oxygen within the muscle cells.1 When the muscle cells are damaged, Myoglobin is released to the blood rapidly due to its relatively small size. Following the death of tissue associated with MI, Myoglobin is one of the first markers to rise above normal levels. The level of Myoglobin increases measurably above baseline within 2-4 hours post-infarct, peaking at 9-12 hours, and returning to baseline within 24-36 hours.2,3 A number of reports suggest the measurement of Myoglobin as a diagnostic aid in confirming the absence of myocardial infarction with negative predictive values of up to 100% reported at certain time periods after onset of symptoms.4

The One Step Myoglobin Rapid Test Device (Whole Blood/Serum/Plasma) is a simple test utilizing a combination of anti-Myoglobin antibody coated particles and capture reagent to detect Myoglobin in whole blood, serum or plasma. The minimum detection level is 50 ng/mL.

Inquiry Cart 0